Literature DB >> 21748976

Oral cancer: enduring characteristics and emerging trends.

Molly S Rosebush1, Shailaja Kishan Rao, Sandeep Samant, Weikuan Gu, Charles R Handorf, Lawrence M Pfeffer, Christopher A Nosrat.   

Abstract

Oral cancer is arguably the most serious condition that dental providers may encounter in their practice. The relatively poor prognosis associated with oral cancer highlights the importance of the dental team's awareness of the disease. While many characteristics of oral cancer have endured over time, new research is revealing trends that are changing the way we approach its screening, diagnosis and treatment. In this report, we provide a translational overview of oral cancer, including risk factors, signs and symptoms, clinical management, as well as our recent findings on the role of chronic inflammation in the development of the disease. In addition, our recent genetic profiling approach in both cancer cell lines and in patients has identified potential biomarkers, molecular pathways and therapeutic drugs (Velcade and Aspirin) for oral squamous cell carcinomas. This comprehensive review should be of interest to all dental professionals.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21748976

Source DB:  PubMed          Journal:  J Tenn Dent Assoc        ISSN: 0040-3385


  13 in total

Review 1.  Clinicopathological prognostic implicators of oral squamous cell carcinoma: need to understand and revise.

Authors:  Kiran B Jadhav; Nidhi Gupta
Journal:  N Am J Med Sci       Date:  2013-12

2.  Long non-coding RNA MEG3 inhibits the proliferation and metastasis of oral squamous cell carcinoma by regulating the WNT/β-catenin signaling pathway.

Authors:  Zongxiang Liu; Cui Wu; Nina Xie; Penglai Wang
Journal:  Oncol Lett       Date:  2017-07-27       Impact factor: 2.967

3.  Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.

Authors:  Vinay K Kartha; Khalid A Alamoud; Khikmet Sadykov; Bach-Cuc Nguyen; Fabrice Laroche; Hui Feng; Jina Lee; Sara I Pai; Xaralabos Varelas; Ann Marie Egloff; Jennifer E Snyder-Cappione; Anna C Belkina; Manish V Bais; Stefano Monti; Maria A Kukuruzinska
Journal:  Genome Med       Date:  2018-07-20       Impact factor: 11.117

4.  Clinical Significance of the Decreased Expression of hsa_circ_001242 in Oral Squamous Cell Carcinoma.

Authors:  Shuai Sun; Bowen Li; Yufan Wang; Xiang Li; Panpan Wang; Feng Wang; Wei Zhang; Hongyu Yang
Journal:  Dis Markers       Date:  2018-07-04       Impact factor: 3.434

5.  Ten-Year Outcome of Different Treatment Modalities for Squamous Cell Carcinoma of Oral Cavity

Authors:  Imjai Chitapanarux; Patrinee Traisathit; Nicha Komolmalai; Sompol Chuachamsai; Pichit Sittitrai; Tienchai Pattarasakulchai; Rak Tananuwat; Donyarat Boonlert; Patumrat Sripan; Anak Iamaroon
Journal:  Asian Pac J Cancer Prev       Date:  2017-07-27

6.  M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.

Authors:  Guang-Zhao Huang; Qing-Qing Wu; Ze-Nan Zheng; Ting-Ru Shao; Yue-Chuan Chen; Wei-Sen Zeng; Xiao-Zhi Lv
Journal:  Aging (Albany NY)       Date:  2020-06-11       Impact factor: 5.682

7.  Cervical Lymph Node Metastases in Oral Squamous Cell Carcinoma-How Much Imaging Do We Need?

Authors:  Johannes Laimer; Anke Lauinger; Otto Steinmassl; Vincent Offermanns; Astrid E Grams; Bettina Zelger; Emanuel Bruckmoser
Journal:  Diagnostics (Basel)       Date:  2020-04-02

8.  Circular RNA Expression in Oral Squamous Cell Carcinoma.

Authors:  Yu-Fan Wang; Bo-Wen Li; Shuai Sun; Xiang Li; Wen Su; Zhi-Hong Wang; Feng Wang; Wei Zhang; Hong-Yu Yang
Journal:  Front Oncol       Date:  2018-10-08       Impact factor: 6.244

9.  Hsa_circ_0008309 May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.

Authors:  Bowen Li; Feng Wang; Xiang Li; Shuai Sun; Yuehong Shen; Hongyu Yang
Journal:  Dis Markers       Date:  2018-09-23       Impact factor: 3.434

10.  Long non-coding RNA LINC00662 promotes proliferation and migration in oral squamous cell carcinoma.

Authors:  Debin Xu; Yunmei Chen; Chunlei Yuan; Shuyong Zhang; Wei Peng
Journal:  Onco Targets Ther       Date:  2019-01-18       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.